U.S. flag

An official website of the United States government

NM_001673.5(ASNS):c.1628A>G (p.Asn543Ser) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jun 8, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001581911.4

Allele description [Variation Report for NM_001673.5(ASNS):c.1628A>G (p.Asn543Ser)]

NM_001673.5(ASNS):c.1628A>G (p.Asn543Ser)

Genes:
CZ1P-ASNS:CZ1P-ASNS readthrough [Gene]
ASNS:asparagine synthetase (glutamine-hydrolyzing) [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q21.3
Genomic location:
Preferred name:
NM_001673.5(ASNS):c.1628A>G (p.Asn543Ser)
HGVS:
  • NC_000007.14:g.97852317T>C
  • NG_033870.2:g.81246A>G
  • NM_001178075.2:c.1565A>G
  • NM_001178076.2:c.1379A>G
  • NM_001178077.1:c.1379A>G
  • NM_001352496.2:c.1628A>G
  • NM_001673.5:c.1628A>GMANE SELECT
  • NM_133436.3:c.1628A>G
  • NM_183356.4:c.1628A>G
  • NP_001171546.1:p.Asn522Ser
  • NP_001171547.1:p.Asn460Ser
  • NP_001171548.1:p.Asn460Ser
  • NP_001339425.1:p.Asn543Ser
  • NP_001664.3:p.Asn543Ser
  • NP_597680.2:p.Asn543Ser
  • NP_899199.2:p.Asn543Ser
  • NC_000007.13:g.97481629T>C
  • NR_147989.1:n.3331A>G
Protein change:
N460S
Links:
dbSNP: rs751735389
NCBI 1000 Genomes Browser:
rs751735389
Molecular consequence:
  • NM_001178075.2:c.1565A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001178076.2:c.1379A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001178077.1:c.1379A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001352496.2:c.1628A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001673.5:c.1628A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133436.3:c.1628A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_183356.4:c.1628A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_147989.1:n.3331A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001818064GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)		Uncertain significance
(Apr 30, 2021) 		germlineclinical testing

Citation Link,

SCV003274197Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Uncertain significance
(Jun 8, 2022) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From GeneDx, SCV001818064.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV003274197.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 543 of the ASNS protein (p.Asn543Ser). This variant is present in population databases (rs751735389, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with ASNS-related conditions. ClinVar contains an entry for this variant (Variation ID: 1214177). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ASNS protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023